Cancer cells obtained from a blood test may be able to predict how early-stage lung cancer patients will fare, a team from the University of Michigan has shown. This information could be used to determine which patients are most likely to benefit from additional therapies to head off the spread of the cancer to other areas of the body.
Author: Rosemary Clandos Media contact: Nicole Fawcett, 734-764-2220 | Patients may contact Cancer AnswerLine™, &
Individual acupressure points linked to specific centers in the brain can offer targeted relief for breast cancer patients with persistent fatigue, according to a new neuroimaging study.
Reuters reports on a study published in European Urology that shows that black men in America with medium- and high-risk prostate tumors are less likely to get aggressive treatment than white men are.
An experimental drug combined with the traditional chemotherapy drug cisplatin, when used in mice, destroyed a rare form of salivary gland tumor and prevented a recurrence within 300 days, a University of Michigan study found.
University of Michigan Comprehensive Cancer Center ranked No. 12 in the country by U.S. News & World Report
Ranked No. 1 in Michigan and No. 12 in the country, The University of Michigan Comprehensive Cancer Center was recognized as among the best in the nation by U.S. News & World Report for 2017-2018.
A new study shows just how complex metastatic cancer is and offers some clues to attacking it. The study represents one of the largest and most comprehensive efforts to examine the genetic and molecular landscape of advanced cancer.
Michigan Medicine experts discuss whether active surveillance could reduce overtreatment for some thyroid, prostate and breast cancers
Appropriate Distress Screening and Follow Up Leads to Fewer ER Visits and Hospitalizations in Patients with Cancer, Study Finds
Following a cancer diagnosis, all patients experience some level of distress -- regardless of disease stage. When severe and left untreated, distress can have a significant impact on health outcomes, lead to greater mortality and morbidity, affect immune function, and result in higher health care expenditures.
The University of Michigan Comprehensive Cancer Center Research Committee recently awarded $340,000 in grants to faculty for cancer-related research.